666 related articles for article (PubMed ID: 23537975)
1. Iron deficiency in chronic heart failure: an international pooled analysis.
Klip IT; Comin-Colet J; Voors AA; Ponikowski P; Enjuanes C; Banasiak W; Lok DJ; Rosentryt P; Torrens A; Polonski L; van Veldhuisen DJ; van der Meer P; Jankowska EA
Am Heart J; 2013 Apr; 165(4):575-582.e3. PubMed ID: 23537975
[TBL] [Abstract][Full Text] [Related]
2. Vitamin B12 and folate deficiency in chronic heart failure.
van der Wal HH; Comin-Colet J; Klip IT; Enjuanes C; Grote Beverborg N; Voors AA; Banasiak W; van Veldhuisen DJ; Bruguera J; Ponikowski P; Jankowska EA; van der Meer P
Heart; 2015 Feb; 101(4):302-10. PubMed ID: 25324534
[TBL] [Abstract][Full Text] [Related]
3. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
Okonko DO; Mandal AK; Missouris CG; Poole-Wilson PA
J Am Coll Cardiol; 2011 Sep; 58(12):1241-51. PubMed ID: 21903058
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
[TBL] [Abstract][Full Text] [Related]
5. Iron deficiency status irrespective of anemia: a predictor of unfavorable outcome in chronic heart failure patients.
Rangel I; Gonçalves A; de Sousa C; Leite S; Campelo M; Martins E; Amorim S; Moura B; Silva Cardoso J; Maciel MJ
Cardiology; 2014; 128(4):320-6. PubMed ID: 24924145
[TBL] [Abstract][Full Text] [Related]
6. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use.
van der Wal HH; Grote Beverborg N; Dickstein K; Anker SD; Lang CC; Ng LL; van Veldhuisen DJ; Voors AA; van der Meer P
Eur Heart J; 2019 Nov; 40(44):3616-3625. PubMed ID: 31556953
[TBL] [Abstract][Full Text] [Related]
7. The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences.
Klip IT; Jankowska EA; Enjuanes C; Voors AA; Banasiak W; Bruguera J; Rozentryt P; Polonski L; van Veldhuisen DJ; Ponikowski P; Comin-Colet J; van der Meer P
Eur J Heart Fail; 2014 Jun; 16(6):655-62. PubMed ID: 24644024
[TBL] [Abstract][Full Text] [Related]
8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
[TBL] [Abstract][Full Text] [Related]
10. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.
Jankowska EA; Rozentryt P; Witkowska A; Nowak J; Hartmann O; Ponikowska B; Borodulin-Nadzieja L; von Haehling S; Doehner W; Banasiak W; Polonski L; Filippatos G; Anker SD; Ponikowski P
J Card Fail; 2011 Nov; 17(11):899-906. PubMed ID: 22041326
[TBL] [Abstract][Full Text] [Related]
11. Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients.
Schou M; Bosselmann H; Gaborit F; Iversen K; Goetze JP; Soletomas G; Rasmussen J; Kistorp C; Kober L; Gustafsson F; Tonder N
Int J Cardiol; 2015 Sep; 195():143-8. PubMed ID: 26043148
[TBL] [Abstract][Full Text] [Related]
12. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
13. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
Ebner N; Jankowska EA; Ponikowski P; Lainscak M; Elsner S; Sliziuk V; Steinbeck L; Kube J; Bekfani T; Scherbakov N; Valentova M; Sandek A; Doehner W; Springer J; Anker SD; von Haehling S
Int J Cardiol; 2016 Feb; 205():6-12. PubMed ID: 26705670
[TBL] [Abstract][Full Text] [Related]
14. Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis.
Yeo TJ; Yeo PS; Ching-Chiew Wong R; Ong HY; Leong KT; Jaufeerally F; Sim D; Santhanakrishnan R; Lim SL; M Y Chan M; Chai P; Low AF; Ling LH; Ng TP; Richards AM; Lam CS
Eur J Heart Fail; 2014 Oct; 16(10):1125-32. PubMed ID: 25208495
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up study.
Wienbergen H; Pfister O; Hochadel M; Fach A; Backhaus T; Bruder O; Remppis BA; Maeder MT; von Scheidt W; Pauschinger M; Senges J; Hambrecht R;
Clin Res Cardiol; 2019 Jan; 108(1):93-100. PubMed ID: 30003365
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
Richter B; Koller L; Hohensinner PJ; Rychli K; Zorn G; Goliasch G; Berger R; Mörtl D; Maurer G; Huber K; Pacher R; Wojta J; Hülsmann M; Niessner A
Thromb Haemost; 2012 Dec; 108(6):1220-7. PubMed ID: 23014777
[TBL] [Abstract][Full Text] [Related]
17. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
18. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
19. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
20. Iron deficiency and red cell indices in patients with heart failure.
Tkaczyszyn M; Comín-Colet J; Voors AA; van Veldhuisen DJ; Enjuanes C; Moliner-Borja P; Rozentryt P; Poloński L; Banasiak W; Ponikowski P; van der Meer P; Jankowska EA
Eur J Heart Fail; 2018 Jan; 20(1):114-122. PubMed ID: 28386910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
